Last update 16 Jul 2025

Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ipragliflozin L-proline/sitagliptin, Sitagliptin/ipragliflozin, Sitagliptin/ipragliflozin L-proline
+ [4]
Target
DPP-4 x SGLT2
Action
inhibitors
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Astellas Pharma, Inc.Astellas Pharma, Inc.
Active Organization
MSD (Japan) Co., Ltd.
Inactive Organization-
License Organization
Merck & Co., Inc.Merck & Co., Inc.Astellas Pharma, Inc.Astellas Pharma, Inc.
Drug Highest PhaseApproved
First Approval Date
Japan (23 Mar 2018),
Diabetes Mellitus, Type 2
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC16H20F6N5O6P
InChIKeyGQPYTJVDPQTBQC-KLQYNRQASA-N
CAS Registry654671-77-9
View All Structures (2)

Related

100 Clinical Results associated with Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline
Login to view more data
100 Translational Medicine associated with Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline
Login to view more data
100 Patents (Medical) associated with Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline
Login to view more data
100 Deals associated with Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
A10B
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
Japan
MSD (Japan) Co., Ltd.
23 Mar 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free